EP Patent

EP3873510B1 — Thiostrepton and vitamin e-tpgs for treating cancer

Assigned to Rs Oncology LLC · Expires 2025-04-30 · 1y expired

What this patent protects

Patent listed against thiotepa.

Drugs covered by this patent

thiotepa (THIOTEPA)

Patent Metadata

Patent number: EP3873510B1
Jurisdiction: EP
Classification: —
Expires: 2025-04-30
Drug substance claim: No
Drug product claim: No
Assignee: Rs Oncology LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.